05:12 PM EDT, 10/29/2024 (MT Newswires) -- Chemed ( CHE ) reported Q3 adjusted earnings late Tuesday of $5.64 per diluted share, up from $5.32 a year earlier.

Two analysts surveyed by Capital IQ expected $5.76.

Revenue for the quarter ended Sept. 30 was $606.2 million, up from $564.5 million a year earlier.

Two analysts surveyed by Capital IQ expected $612.2 million.

The company now expects full-year 2024 adjusted EPS of $23.00 to $23.15, down from its previous guidance of $23.55 to $23.80.

Three analysts surveyed by Capital IQ expect $23.56.

Price: 604.59, Change: -5.21, Percent Change: -0.85